Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Synereca Pharmaceuticals
company
About
Synereca Pharmaceuticals develops orally-active drugs that restore the effectiveness of existing antibiotics.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $600K
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2M
Synereca Pharmaceuticals has raised a total of
$2M
in funding over 2 rounds. Their latest funding was raised on
Aug 4, 2015 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 4, 2015 | Series Unknown | $600K | 1 |
Accele Venture Partners
|
— | Detail |
| Sep 16, 2014 | Debt Financing | $1.40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Synereca Pharmaceuticals is funded by 1 investors.
Accele Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Accele Venture Partners
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
